Abstract
Enzymes belonging to the PLA2 superfamily catalyze the hydrolysis of unsaturated fatty acids from the sn-2 position of glycerol moiety of neural membrane phospholipids. The PLA2 superfamily is classified into cytosolic PLA2 (cPLA2), calcium-independent PLA2 (iPLA2), plasmalogen-selective PLA2 (PlsEtn-PLA2) and secretory PLA2 (sPLA2). PLA2 paralogs/splice variants/isozymes are part of a complex signal transduction network that maintains cross-talk among excitatory amino acid and dopamine receptors through the generation of second messengers. Individual paralogs, splice variants and multiple forms of PLA2 may have unique enzymatic properties, tissue and subcellular localizations and roles in various physiological and pathological situations, hence tight regulation of all PLA2 isoforms is essential for normal brain function. Quantitative RT-PCR analyses show significantly higher expression of iPLA2 than cPLA2 in all regions of the rat brain. Upregulation of the cPLA2 family is involved in degradation of neural membrane phospholipids and generation of arachidonic acid-derived lipid metabolites that have been implicated in nociception, neuroinflammation, oxidative stress and neurodegeneration. In contrast, studies using a selective iPLA2 inhibitor, bromoenol lactone, or antisense oligonucleotide indicate that iPLA2 is an important “housekeeping” enzyme under normal conditions, whose activity is required for the prevention of vacuous chewing movements, and deficits in prepulse inhibition of the auditory startle reflex, a finding in human patients with schizophrenia. These studies support the view that PLA2 activity may not only play a crucial role in neurodegeneration, but depending on the isoform, could also be essential in prevention of neuropsychiatric diseases. These findings could open new doors for understanding and treatment of neurodegenerative and neuropsychiatric diseases.
Keywords: Cytosolic phospholipase A2, calcium-independent phospholipase A2, plasmalogen-selective phospholipase A2, secretory phospholipase A2, arachidonic acid, docosahexaenoic acid, reactive oxygen species, oxidative stress, inflammation, excitotoxicity, mitochondna schizophrenia
Current Medicinal Chemistry
Title: Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions
Volume: 17 Issue: 25
Author(s): W.-Y. Ong, T. Farooqui and A.A. Farooqui
Affiliation:
Keywords: Cytosolic phospholipase A2, calcium-independent phospholipase A2, plasmalogen-selective phospholipase A2, secretory phospholipase A2, arachidonic acid, docosahexaenoic acid, reactive oxygen species, oxidative stress, inflammation, excitotoxicity, mitochondna schizophrenia
Abstract: Enzymes belonging to the PLA2 superfamily catalyze the hydrolysis of unsaturated fatty acids from the sn-2 position of glycerol moiety of neural membrane phospholipids. The PLA2 superfamily is classified into cytosolic PLA2 (cPLA2), calcium-independent PLA2 (iPLA2), plasmalogen-selective PLA2 (PlsEtn-PLA2) and secretory PLA2 (sPLA2). PLA2 paralogs/splice variants/isozymes are part of a complex signal transduction network that maintains cross-talk among excitatory amino acid and dopamine receptors through the generation of second messengers. Individual paralogs, splice variants and multiple forms of PLA2 may have unique enzymatic properties, tissue and subcellular localizations and roles in various physiological and pathological situations, hence tight regulation of all PLA2 isoforms is essential for normal brain function. Quantitative RT-PCR analyses show significantly higher expression of iPLA2 than cPLA2 in all regions of the rat brain. Upregulation of the cPLA2 family is involved in degradation of neural membrane phospholipids and generation of arachidonic acid-derived lipid metabolites that have been implicated in nociception, neuroinflammation, oxidative stress and neurodegeneration. In contrast, studies using a selective iPLA2 inhibitor, bromoenol lactone, or antisense oligonucleotide indicate that iPLA2 is an important “housekeeping” enzyme under normal conditions, whose activity is required for the prevention of vacuous chewing movements, and deficits in prepulse inhibition of the auditory startle reflex, a finding in human patients with schizophrenia. These studies support the view that PLA2 activity may not only play a crucial role in neurodegeneration, but depending on the isoform, could also be essential in prevention of neuropsychiatric diseases. These findings could open new doors for understanding and treatment of neurodegenerative and neuropsychiatric diseases.
Export Options
About this article
Cite this article as:
Ong W.-Y., Farooqui T. and Farooqui A.A., Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions, Current Medicinal Chemistry 2010; 17 (25) . https://dx.doi.org/10.2174/092986710791859289
DOI https://dx.doi.org/10.2174/092986710791859289 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/β-catenin Signaling
Current Topics in Medicinal Chemistry The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Current Molecular Pharmacology Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity
Current Medicinal Chemistry Pharmacological and Cellular Therapies to Prevent Restenosis after Percutaneous Transluminal Angioplasty and Stenting
Cardiovascular & Hematological Agents in Medicinal Chemistry Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Carotid Intima Media Thickness and Beyond
Current Drug Targets - Cardiovascular & Hematological Disorders Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
Current Immunology Reviews (Discontinued) Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews Advances in Nanomaterials for Diagnosis and Therapy of Leukemia
Recent Patents on Nanomedicine Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Acute Kidney Injury, Hyperbilirubinemia, and Ischemic Skin Necrosis Due to Massive Sulindac Overdose
Current Drug Safety Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Bleomycin and its Role in Inducing Apoptosis and Senescence in Lung Cells - Modulating Effects of Caveolin-1
Current Cancer Drug Targets The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design Host Genetic Factors and Treatment of Hepatitis C
Current Molecular Pharmacology Lipogenic Enzymes as Therapeutic Targets for Obesity and Diabetes
Current Pharmaceutical Design